Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model

Published:2021-07 Issue:7 Volume:1867 Page:166151
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Zhao Yun,Peng Xiaoxia,Baldwin Hope,Zhang Chao,Liu Zhongmin,Lu Xin

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China Stem Cell and Translational Research

Boler Family Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Treatment of advanced prostate cancer-a review of current therapies and future promise;Sumanasuriya;Cold Spring Harb. Perspect. Med.,2018

3. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer;Watson;Nat. Rev. Cancer,2015

4. Advanced prostate cancer: treatment advances and future directions;Swami;Trends Cancer,2020

5. Translational models of prostate cancer bone metastasis;Berish;Nat. Rev. Urol.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer;Asian Journal of Andrology;2023

2. Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer;Biomolecules;2022-10-28

3. Circulating PMN-MDSC level positively correlates with a poor prognosis in patients with metastatic hormone-sensitive prostate cancer;Frontiers in Urology;2022-09-15

4. Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3